Amal Therapeutics Email Format
Biotechnology ResearchGeneva, Switzerland11-50 Employees
Amal Therapeutics is a biotechnology company based in Geneva, Switzerland, operating within the biotechnology research sector. It concentrates on therapeutic cancer vaccines, a field that was advanced when Boehringer Ingelheim acquired Amal Therapeutics in 2019. The firm maintains a small to mid-sized team. This focus on cancer vaccine technology places Amal in the oncology segment of biotech research. It is based in the Geneva region.